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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYThe detailed mechanism of reprogramming somatic cells into induced pluripotent stem cells (iPSCs) remains largely unknown. Partially
reprogrammed iPSCs are informative and useful for understanding the mechanism of reprogramming but remain technically difficult to
generate in a predictable and reproducible manner. Using replication-defective and persistent Sendai virus (SeVdp) vectors, we analyzed
the effect of decreasing the expression levels of OCT4, SOX2, KLF4, and c-MYC and found that low KLF4 expression reproducibly gives
rise to a homogeneous population of partially reprogrammed iPSCs. Upregulation of KLF4 allows these cells to resume reprogramming,
indicating that they are paused iPSCs that remain on the path toward pluripotency. Paused iPSCs with different KLF4 expression levels
remain at distinct intermediate stages of reprogramming. This SeVdp-based stage-specific reprogramming system (3S reprogramming
system) is applicable for both mouse and human somatic cells and will facilitate the mechanistic analysis of reprogramming.INTRODUCTION
Induced pluripotent stem cells (iPSCs) can be generated by
introducing OCT4, SOX2, KLF4, and c-MYC (Takahashi
et al., 2007; Takahashi and Yamanaka, 2006) or other com-
binations of reprogramming factors (Stadtfeld and Ho-
chedlinger, 2010) into many types of mouse and human
somatic cells. The understanding of its mechanism is
crucial for generating high-quality iPSCs for cell therapy
applications and also provides an insight into reprogram-
ming and normal development. The reprogramming is an
orderly process consisting of distinct stages, which can be
distinguished by expression of specific markers, including
stage-specific embryonic antigen-1 (SSEA-1), alkaline phos-
phatase (ALP), E-Cadherin (CDH1), and NANOG (Bram-
brink et al., 2008; Samavarchi-Tehrani et al., 2010; Stadtfeld
et al., 2008). However, the precise molecular mechanisms
behind iPSC generation remain to be elucidated.
Reprogramming mechanisms have been investigated
by cell sorting a subpopulation of intermediate cells that
express a specific combination of markers. These enriched
cells are initially at a specific intermediate stage but
continue reprogramming upon further cell culture, subse-
quently becoming a heterogeneous population of asyn-
chronously reprogrammed cells (Hansson et al., 2012;
O’Malley et al., 2013; Polo et al., 2012; Takahashi et al.,
2014). Alternatively, more stable cell populations, isolated
during iPSC generation, were also used for mechanistic an-
alyses (Mikkelsen et al., 2008; Sridharan et al., 2009). These
cells show phenotypes that are intermediate between so-
matic cells and iPSCs, thereby yielding mechanistic in-Stem Cell Rsights into reprogramming. Despite their usefulness, the
stable cell populations are derived from rare by-products
that appear sporadically during iPSC generation and diffi-
cult to obtain reproducibly in a predictable manner.
The efficiency of reprogramming and the characteristics
of iPSCs are influenced by the expression levels and stoichi-
ometry of reprogramming factors (Carey et al., 2011; Naga-
matsu et al., 2012; Papapetrou et al., 2009; Sui et al., 2014;
Tiemann et al., 2011). Detailed quantitative analyses show
that merely increasing the expression levels of OCT4,
SOX2, KLF4, and c-MYC does not necessarily lead to higher
efficiency of iPSC generation; rather, the stoichiometry of
the four factors plays a greater role in the efficiency of
iPSC generation (Nagamatsu et al., 2012; Papapetrou et al.,
2009; Tiemann et al., 2011). For example, high OCT4 and
low SOX2 expression levels relative to other factors tend
to generate iPSCs more efficiently than equal expression
levels of the four factors. In addition, the reprogramming
factor stoichiometry influences the gene expression pattern
(Nagamatsu et al., 2012; Tiemann et al., 2011) and epige-
netic status of iPSCs (Carey et al., 2011) as well as their
ability to contribute to chimeric mice (Carey et al., 2011),
suggesting that the stoichiometry of reprogramming factors
may impact the reprogramming process as well.
We previously developed a unique gene transfer system,
named SeVdp vectors, based on a mutant strain of Sendai
virus, which remains persistently in the cytoplasmwithout
integrating into the host genome (Nishimura et al., 2007).
SeVdp vectors enable a long-term expression of multiple
genes from a single vector with a constant stoichiom-
etry and do not suffer from transcriptional silencingeports j Vol. 3 j 915–929 j November 11, 2014 j ª2014 The Authors 915
Figure 1. Generation of Partially Reprogrammed iPSCs by SeVdp Vectors
(A) Structures of SeVdp(KOSM) and SeVdp(GKOSM).
(B) Expression of ESC markers. Colonies induced by SeVdp(KOSM) or SeVdp(GKOSM) were stained for ALP or SSEA-1 at day 10 or 18,
respectively. Scale bars, 100 mm.
(C) Time course of mRNA expression. Cells were collected at day 0, 6, 13, 25, and 49, and the mRNA levels of indicated genes were
determined by quantitative RT-PCR and plotted relative to those in MEFs or mouse iPSCs (miPSC) (Nishimura et al., 2011). Data represent
means ± SEM of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001 versus SeVdp(KOSM)-infected cells.
(D) Reproducibility of reprogramming by SeVdp(GKOSM). Cells were collected at day 25 (Exp. 1) or day 23 (Exp. 2 and 3), and the mRNA
levels of Cdh1, Fgf4, and Rex1 were determined by quantitative RT-PCR. Data represent means ± SEM of three independent PCR reactions.
n.s., not significant; ***p < 0.001 versus Exp. 1.
(legend continued on next page)
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vectors an ideal tool for generating iPSCs. In fact, SeVdp
vectors harboring four reprogramming factors (OCT4,
SOX2, KLF4, and c-MYC) reprogrammouse and human so-
matic cells very efficiently (Nishimura et al., 2011; Nishi-
mura et al., 2013; Takayama et al., 2010; Tateno et al.,
2013; Wakao et al., 2013).
Here, we report the SeVdp-based stage-specific reprog-
ramming system (3S reprogramming system) that gener-
ates paused iPSCs by controlling the KLF4 expression level
with a destabilization domain (DD) and a small molecule,
Shield1. We found that low KLF4 expression gives rise to
partially reprogrammed cells, which are stably arrested at
different stages of reprogramming depending on the level
of KLF4 expression. Global gene expression analyses
support that the partially reprogrammed iPSCs show
intermediate gene expression profiles. Upregulation of
KLF4 expression by Shield1 addition allows the partially
reprogrammed cells to resume reprogramming toward
pluripotency. The 3S reprogramming system establishes
homogenous populations of paused iPSCs in a reproduc-
ible and predictable manner and is applicable for both
mouse and human cells.RESULTS
Induction of Partially Reprogrammed Cells by SeVdp
Vectors
In the course of developing SeVdp vectors for reprogram-
ming, we created a vector named SeVdp(GKOSM) (Fig-
ure 1A), which is derived from SeVdp(KOSM) that induces
fully reprogrammed iPSCs (Nishimura et al., 2011; Nishi-
mura et al., 2013; Wakao et al., 2013). SeVdp(GKOSM) en-
codes EGFP in addition to KLF4, OCT4, SOX2, and c-MYC
and enables monitoring of the SeVdp vector in living cells
during reprogramming (FigureS1Aavailableonline).Mouse
embryonicfibroblasts (MEFs) infectedwithSeVdp(GKOSM)
or SeVdp(KOSM) gave rise to almost the same number
of ALP-positive (ALP+) colonies (Table S1) consisting of
small and rapidly growing cells (Figure 1B). Indeed, the col-
onies induced by SeVdp(GKOSM) were morphologically
indistinguishable from SeVdp(KOSM)-induced ones, as
exemplified by the cellular localization of b-CATENIN (Fig-
ures 1B and S1B). However, the colonies induced by
SeVdp(GKOSM) were negative for SSEA-1 as opposed to
the ones induced by SeVdp(KOSM), which were positive(E) Protein levels of reprogramming factors expressed from SeVdp vec
1 day after infection, and the protein level of each reprogramming
Experimental Procedures. The protein level of each factor is plotted rel
SEM of three independent experiments. **p < 0.01.
See also Figure S1 and Tables S1 and S2.
Stem Cell Rfor SSEA-1 (Figure 1B). Expression of Thy1, Snail1, Snail2,
and Tgfb3 was repressed 6 days after infection in the cells
induced by SeVdp(GKOSM) and SeVdp(KOSM) (Figure 1C),
consistent with the downregulation of somatic cell-specific
genes at the early stage of reprogramming (Stadtfeld et al.,
2008). On the other hand, at day 49, expression of mesen-
chymal-specific genes such as Cdh2, Zeb1, Zeb2, and Twist1
remained higher in SeVdp(GKOSM)-induced cells than in
SeVdp(KOSM)-induced ones (Figure 1C), indicating that
the SeVdp(GKOSM)-induced cells have not completed the
mesenchymal-to-epithelial transition (MET), which nor-
mally occurs during iPSC generation (Li et al., 2010;
Samavarchi-Tehrani et al., 2010). Moreover, these cells
expressed only low levels of embryonic stem cell (ESC)
marker genes including Cdh1, Fgf4, Rex1 (also called
Zfp42), and Nanog even at day 49 (Figure 1C), showing
that they persist as partially reprogrammed cells. Indepen-
dent reprogramming by SeVdp(GKOSM) yielded cells with
low expression levels of Cdh1, Fgf4, and Rex1 reproducibly
(Figure 1D).Quantitativewesternblots (Figure S1C) showed
that expression of all the four reprogramming factors, espe-
cially KLF4, were lower in SeVdp(GKOSM)-infected cells
than in those infected by SeVdp(KOSM) (Figure 1E),
presumably because Sendai virus vectors express genes
located in its 30 region at a higher level than those in
the 50 region (Tokusumi et al., 2002) (Figure 1A), and
the presence of the EGFP gene in the 30 region of
SeVdp(GKOSM) is detrimental for the expression of the
four factors. Thesefindings raise thepossibility that lowered
expression of reprogramming factors induces partially
reprogrammed cells.
Low KLF4 Expression Induces Partially
Reprogrammed Cells
To identify which factor was responsible for partial
reprogramming, we created four different vectors,
SeVdp(fK-OSM), SeVdp(K-fOSM), SeVdp(KO-fSM), and
SeVdp(KOS-fM). In each vector, one of the four factors was
tagged N-terminally with a destabilization domain (DD),
derived from a mutant FKBP12 (Banaszynski et al., 2006)
(Figure 2A). This domain facilitates degradation of the
tagged protein anddecreases its expression level (Figure 2B).
In addition, the DD-tagged protein is stabilized by a low
molecular weight ligand, Shield1, in a precisely controlled
manner (Figure 2B). When each vector was infected
to MEFs in the absence of Shield1, the expression
levels of DD-tagged KLF4, OCT4, SOX2, and c-MYC weretors. SeVdp(KOSM) or SeVdp(GKOSM)-infected MEFs were collected
factor was determined by western blotting as described in the
ative to that in SeVdp(KOSM)-infected cells. Data represent means ±
eports j Vol. 3 j 915–929 j November 11, 2014 j ª2014 The Authors 917
Figure 2. Effects of Downregulated KLF4, OCT4, SOX2, or c-MYC on Reprogramming
(A) Structures of SeVdp vectors in which one of the reprogramming factors is tagged N-terminally with DD.
(B) Stability of DD-tagged reprogramming factor during iPSC generation is regulated by the addition of Shield1.
(C and D) Protein levels of reprogramming factors expressed from SeVdp vectors. Cell extracts were prepared from MEFs infected with each
indicated vector one day after infection in the presence or absence of 100 nM Shield1. The protein level of each reprogramming factor is
determined by western blotting, and the level in the absence of 100 nM Shield1 is plotted relative to that in SeVdp(KOSM)-infected cells (C)
or in the presence of 100 nM Shield1 (D). Data represent means ± SEM of three independent experiments. *p < 0.05, **p < 0.01, ***p <
0.001 versus SeVdp(KOSM) (C) or versus in the presence of 100 nM Shield1 (D).
(E) ALP+ colonies induced by each vector. MEFs (1.03 104) infected with the indicated vector were cultured in the presence or absence of
100 nM Shield1 and stained for ALP at day 13.
(F) Expression of SSEA-1 and NANOG. SSEA-1 was detected by immunofluorescence staining at day 18, and NANOG was detected by GFP
fluorescence from the Nanog-GFP reporter transgene at day 22. Scale bars, 100 mm.
See also Figure S2 and Table S1.
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14.5%of those inMEFs infectedwithSeVdp(KOSM), but the
threeothernontagged factorsdidnot showsimilardecreases918 Stem Cell Reports j Vol. 3 j 915–929 j November 11, 2014 j ª2014 Thein expression (Figure 2C). Moreover, the expression levels
of DD-tagged KLF4, OCT4, SOX2, and c-MYC in the
absence of Shield1 were 34.9% ± 6.2%, 40.3% ± 20.7%,Authors
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of 100 nM Shield1, but the three other nontagged factors
showed lesser fluctuations in their expression levels by the
addition of Shield1 (Figure 2D).
SeVdp(K-fOSM), SeVdp(KO-fSM), and SeVdp(KOS-fM)
gave rise to smaller numbers of ALP+ colonies in the
absence of Shield1 than in the presence of 100 nM Shield1
or by the infection with SeVdp(KOSM) (Figure 2E;
Table S1). However, these colonies in the absence of
Shield1 were positive for SSEA-1 and NANOG (Figure 2F)
and far more advanced in reprogramming than the
SeVdp(GKOSM)-induced colonies (Figure 1B), indicating
that low levels of OCT4, SOX2, and c-MYC merely reduce
the efficiency of generating fully reprogrammed iPSCs. By
contrast, SeVdp(fK-OSM) gave rise to similar numbers of
ALP+ colonies as compared with SeVdp(KOSM) (Figure 2E;
Table S1). Moreover, the number of ALP+ colonies induced
by SeVdp(fK-OSM) was essentially the same regardless of
the presence of Shield1 (Figure 2E; Table S1), and the col-
onies induced in the absence of Shield1 were negative for
SSEA-1 and NANOG (Figure 2F), displaying a phenotype
common with the SeVdp(GKOSM)-induced ones (Fig-
ure 1B). Thus, low KLF4 expression in SeVdp(GKOSM)-
infected cells is the main cause of generating partially
reprogrammed iPSCs, and this phenomenon can be reca-
pitulated by SeVdp(fK-OSM) in the absence of Shield1.
To further confirm that partially reprogrammed iPSCs
were induced by low KLF4 expression, we prepared vectors
that express KLF4 tagged C-terminally to the PEST or CL1
degradation signal (Gilon et al., 1998; Rogers et al., 1986)
(Figure S2A). When KLF4 was tagged only with PEST
[SeVdp(Kp-OSM)], KLF4 expression was decreased only
moderately (48.0% ± 7.8%) (Figure S2B), and the induced
cells were not only positive for ALP (Figure S2C) but also
expressed ESC markers, Cdh1, Fgf4, and Rex1 (Figure S2D).
Tagging KLF4 with both PEST and CL1 [SeVdp(Kcp-OSM)]
decreased KLF4 expression slightly lower than that by
SeVdp(fK-OSM) in the absence of Shield1 (23.8% ±
13.6%) (Figure S2B). Indeed, SeVdp(Kcp-OSM) induced
ALP+ colonies (Figure S2C) that did not express ESC
markers (Figure S2D), indicating that the induced cells
are partially reprogrammed as in the case of SeVdp(fK-
OSM) (Figures 2E and 2F). However, removal of KLF4
[SeVdp(OSM)] resulted in a drastically reduced number of
colonies (Figure S2C). These results show that partially re-
programmed iPSCs are generated by low KLF4 expression
and not by the untoward effect by the tagged DD.
Different Levels of KLF4 Expression Reprogram Cells
to Different Degrees
We next examined if iPSCs generated by SeVdp(fK-OSM)
acquire pluripotency when KLF4 expression is increased
by Shield1. When SeVdp(fK-OSM) was infected to MEFsStem Cell Rin the presence of 100 or 200 nM Shield1, the KLF4 expres-
sion level was restored almost to that by SeVdp(KOSM)
(Figure 3A), which generates iPSCs that contribute to
mouse chimeras (Nishimura et al., 2011). Expression ana-
lyses showed that cells induced by SeVdp(fK-OSM) in the
presence of 100 nM Shield1 expressed the 12 marker
genes in analogous time courses to those induced by
SeVdp(KOSM) (Figure 3B). By contrast, the cells induced
by SeVdp(fK-OSM) in the absence of Shield1 failed to
completely downregulate MET-related genes and to upre-
gulate ESC marker genes, displaying gene expression
patterns similar to SeVdp(GKOSM)-induced cells (Figures
1C and 3B). As in the case of the colonies induced
by SeVdp(GKOSM), the expression and localization of
b-CATENIN in SeVdp(fK-OSM)-induced colonies were
indistinguishable from those in SeVdp(KOSM)-induced
ones (Figure S1B). Importantly, addition of Shield1 to the
cells induced by SeVdp(Kcp-OSM) was not accompanied
by the expression of the ESC-specific marker genes (Fig-
ure S2D), showing that Shield1 itself has no effect on
induction of pluripotency.
These iPSCs, induced in the presence of 100 nM Shield1,
were easily cleared of the SeVdp(fK-OSM) genome by an
small interfering RNA (siRNA) against the L gene (Nishi-
mura et al., 2011) that encodes the viral polymerase (Fig-
ures 2A and 3C), confirming that they have acquired
a self-sustaining pluripotency state. When injected
into mouse blastocysts, the vector-free iPSCs (Sh100-36)
contributed to mouse chimeras, which subsequently gave
rise to a live pup (236-18-3) carrying the Nanog-GFP trans-
gene (Figure 3D). Thus, in the presence of 100 nM Shield1,
DD-tagged KLF4 functions indistinguishably from non-
tagged KLF4 and permits SeVdp(fK-OSM) to reprogram
MEFs to acquire pluripotency.
We then used SeVdp(fK-OSM) and different concentra-
tions of Shield1 to analyze the dose-dependent effect of
KLF4 on the reprogramming process. Infection of MEFs
with SeVdp(fK-OSM) in the presence of 10, 30, or 100 nM
Shield1 increased the KLF4 level in a dose-dependent
manner while maintaining the expression of OCT4,
SOX2, and c-MYC essentially unchanged (Figure 3E). In
the presence of 10 or 30 nM Shield1, SeVdp(fK-OSM)
gave rise to reprogrammed cells, most of which expressed
SSEA-1, but not NANOG. The reprogramming of these cells
is more advanced than ALP+, SSEA-1-negative (SSEA-1),
NANOG cells induced by SeVdp(fK-OSM) in the absence
of Shield1 but less advanced than ALP+, SSEA-1+, NANOG+
cells induced by SeVdp(fK-OSM) in the presence of 100 nM
Shield1 (Figure 3F) or by SeVdp(KOSM) (Figure 2F). The
intermediate degree of reprogramming is also supported
by the expression levels ofCdh1, Fgf4, and Rex1 (Figure 3G).
It is of note that independently performed reprog-
ramming by SeVdp(fK-OSM) yielded cells with similareports j Vol. 3 j 915–929 j November 11, 2014 j ª2014 The Authors 919
Figure 3. iPSC Generation by Manipulating the Protein Level of Exogenous KLF4
(A) Protein levels of reprogramming factors expressed from SeVdp(fK-OSM). Cell extracts were prepared from MEFs infected with
SeVdp(fK-OSM) in the presence of the indicated concentration of Shield1 for one day. Protein levels are plotted relative to those in
SeVdp(KOSM)-infected cells. Data represent means ± SEM of three independent experiments. **p < 0.01 versus SeVdp(KOSM).
(B) Time course of mRNA expression. SeVdp(fK-OSM)- or SeVdp(KOSM)-infected cells cultured in the presence (Sh100) or absence (Sh0)
of 100 nM Shield1 were collected at days 7, 13, and 27 for quantitative RT-PCR. Data represent means ± SEM of three independent
experiments. *p < 0.05, **p < 0.01 versus SeVdp(KOSM)-infected cells.
(C) Vector-free iPSCs generated by SeVdp(fK-OSM). The cells induced by SeVdp(fK-OSM) in the presence of 100 nM of Shield1 (P3) were
treated three times with L527 siRNA (P7), and the vector-free iPSCs were isolated at day 50 (Sh100-36 and Sh100-43). Green, Nanog-GFP.
Red, NP of SeV. Scale bars, 100 mm.
(legend continued on next page)
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showing that generation of partially reprogrammed
iPSCs by SeVdp(fK-OSM) is, by and large, reproducible in
independent experiments. Moreover, in the presence or
absence of 10 nM Shield1, individual colonies isolated
from the same plate showed similar gene expression
profiles of Cdh1 and Fgf4 (Figure S3B), showing that
SeVdp(fK-OSM)-induced colonies in the same plate are
relatively homogeneous. Although Rex1 was expressed at
somewhat varied levels, between 2%and 30%of themiPSC
level, in the independent clones induced in the presence of
10 nM Shield1, this may reflect the intrinsically heteroge-
neous expression of Rex1 in mouse ESCs (Toyooka et al.,
2008). Together, these results demonstrate that low KLF4
expression arrests the reprogramming process prematurely,
and SeVdp(fK-OSM) yields partially reprogrammed iPSCs
arrested at distinct stages depending on the amount of
added Shield1. Given these unique properties, we named
this as SeVdp-based stage-specific reprogramming system
(3S reprogramming system).
Upregulation of KLF4 Expression Allows Partially
Reprogrammed iPSCs to Resume Reprogramming
We addressed whether the partially reprogrammed cells
have arrested but remained on a path toward pluripo-
tency or have diverted from the path and become aber-
rantly reprogrammed. After MEFs were infected by
SeVdp(fK-OSM) in the absence of Shield1 for 17 days,
100 nM Shield1 was added to the cell culture (Figure 4A).
This increased the expression of DD-tagged KLF4 by more
than 3-fold (Figure 4B), as revealed by anti-FKBP12 and
anti-KLF4 antibodies. The upregulation of KLF4 expres-
sion at day 17 caused a gradual increase in the expression
of ESC markers, NANOG (Figure 4C), Cdh1, Fgf4, and Rex1
(Figure 4D), indicating that the cells resumed reprogram-
ming toward pluripotency. Similarly, partially reprog-
rammed cells, initially induced by SeVdp(fK-OSM) in the
presence of 10 or 30 nM Shield1, also showed a gradual
increase in the expression of NANOG upon addition of
100 nM Shield1 (Figure S4). Thus, the partially reprog-
rammed iPSCs generated by the 3S reprogramming sys-
tem are competent to resume reprogramming upon the(D) Production of chimeras from iPSCs established by SeVdp(fK-OSM)
generated by the microinjection of clone Sh100-36 or Sh100-43, and t
The IL-2 gene was amplified as an internal control.
(E) Gradual increase of KLF4 expression by Shield1. Cell extracts wer
SeVdp(KOSM)-infected cells. Data represent means ± SEM of three in
(F) Expression of SSEA-1 (day 27) and NANOG (day 29) in the cells cu
(G) The Cdh1, Fgf4, and Rex1 mRNA levels were determined by quantit
cultured at indicated concentrations of Shield1. Data represent mean
***p < 0.001 versus SeVdp(fK-OSM) in the absence of Shield1.
See also Figures S1 and S3 and Table S2.
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‘‘paused iPSCs.’’
Next, we asked if the paused iPSCs are stable and retain
the ability to resume reprogramming after a long period
of cell culture. We induced partially reprogrammed cells
using SeVdp(fK-OSM) in the absence of Shield1, and indi-
vidual clones were isolated at day 20 and cultured for addi-
tional 30 days under the same condition (Figure 4E). Even
after additional culture for 30 days (between day 20 and
50), the cloned cells, Sh0-2 and Sh0-5, remained negative
for SSEA-1 (Figure 4F) as well as for Cdh1, Fgf4, and Rex1
(Figure 4G). Moreover, addition of 100 nM Shield1 at day
50 allowed the cells to resume reprogramming and to
express SSEA-1 (Figure 4F) as well as Cdh1, Fgf4, and Rex1
(Figure 4G), in similar time courses to those observed for
the cells to which 100 nM Shield1 was added at day 17
(Figure 4D).
To further confirm that increased expression of KLF4,
but not other Shield1-induced genes, allowed the partially
reprogrammed cells to resume reprogramming, we used
retrovirus-mediated gene transfer to introduce KLF4,
OCT4, SOX2, or c-MYC into the paused iPSCs generated
by SeVdp(fK-OSM) in the absence of Shield1. As shown in
Figure 4H, additional expression of KLF4, but not other re-
programming factors, caused the cells to express SSEA-1 to
a similar extent to the iPSCs generated by SeVdp(fK-OSM)
in the presence of 100 nM Shield1, suggesting that the cells
resume reprogramming even when KLF4 is provided by
retrovirus-mediated gene transfer. Together, these results
show that the paused iPSCs generated by the 3S reprogram-
ming system are relatively stable and retain the ability to
resume reprogramming for over a month.
Global Gene Expression Analyses of Paused iPSCs
To further characterize the paused iPSCs, we performed
the analysis of their global gene expression. Hierarchical
clustering of cells using differently expressed genes
(DEGs) between MEFs and mouse iPSCs (miPSCs) (Nishi-
mura et al., 2011) showed that SeVdp(fK-OSM)-induced
cells are more similar to miPSCs than MEFs, and the cells
are clustered together according to the amount of added
Shield1 (Figure 5A). Global gene expression profiles alsoto show germline transmission. Genomic DNAs of the chimeric mice
heir pups were analyzed by PCR to detect the Nanog-GFP transgene.
e prepared as in (A). Protein levels are plotted relative to those in
dependent experiments. *p < 0.05, **p < 0.01.
ltured at indicated concentrations of Shield1. Scale bars, 100 mm.
ative RT-PCR at days 7, 13, and 27 for SeVdp(fK-OSM)-infected cells
s ± SEM of three independent experiments. *p < 0.05, **p < 0.01,
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Figure 4. Upregulation of Exogenous KLF4 Resumes Reprogramming
(A) Outline of the experiments to restart reprogramming in partially reprogrammed iPSCs generated by SeVdp(fK-OSM) through the
addition of Shield1 at day 17.
(B) Upregulation of the DD-tagged KLF4 protein level in partially reprogrammed iPSCs after 5 days of Shield1 addition. The protein levels of
DD-tagged KLF4 or total KLF4 was determined by western blotting using an anti-FKBP or anti-KLF4 antibody, respectively, and were plotted
relative to those in the cells cultured in the absence of Shield1. Data represent means ± SEM of three independent experiments. *p < 0.05.
(C) GFP fluorescence of the Nanog-GFP transgene was observed at indicated time points. Scale bars, 100 mm.
(D) The Cdh1, Fgf4, and Rex1mRNA levels were determined by quantitative RT-PCR at day 16, 27, 36, and 49. 100 nM Shield1 was added at
day 17. Data represent means ± SEM of three independent experiments. *p < 0.05, **p < 0.01 versus no addition of Shield1.
(E) Partially reprogrammed iPSC clones were isolated at day 20 (Sh0-2 and Sh0-5) and cultured in the absence of Shield1 until day 50, when
Shield1 was added.
(F) SSEA-1 expression was analyzed at indicated time points. Scale bars, 100 mm.
(legend continued on next page)
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of Shield1 are stable (Sh0 22d and Sh0 79d, Figure 5A) and
resume reprogramming upon the addition of 100 nM
Shield1 (Sh0/100 79d, Figure 5A). Principal component
analysis indicates that SeVdp(fK-OSM)-induced cells have
paused at intermediate stages between MEFs and miPSCs,
and that the addition of a higher amount of Shield1 repro-
grams the cells closer to miPSCs (Figure S5A). The analysis
also showed that the paused iPSCs generated by SeVdp(fK-
OSM) in the absence of Shield1 resume reprogramming
and advance toward pluripotency upon the addition of
100 nM Shield1 (Figure S5B). A recent study reported that
mesendodermal genes are transiently activated during
reprogramming and subsequently repressed again in iPSCs
(Takahashi et al., 2014). Consistent with this, paused iPSCs
express some of the mesendodermal genes (Eomes, Mixl1,
and T), which are nonetheless repressed in fully reprog-
rammed iPSC produced by SeVdp(KOSM) or SeVdp(fK-
OSM) in the presence of 100 nM Shield1 (Figures S5C–
S5E). These gene expression profiles again confirm that
paused iPSCs are intermediates during reprogramming.
Hierarchical clustering of DEGs also revealed the pres-
ence of five distinct gene groups (Figure 5B). Group D
includes a set of genes whose expression is already downre-
gulated in paused iPSCs (Sh0 22d). The genes in groups A
and B increase expression in a stepwise manner from
MEFs to paused iPSCs (Sh0 22d) and from paused iPSCs
(Sh0 22d) to iPSCs (Sh100 22d), respectively. Pathway anal-
ysis shows that Podocyte-related genes, which are involved
in the epithelial-to-mesenchymal transition (EMT) of
podocytes, are enriched in groups A and D (Figure 5C),
indicating that the mesenchymal-to-epithelial transition
(MET), a reverse process of EMT, separates paused iPSCs
(Sh0 22d) fromMEFs. This result is consistent with a previ-
ous report that showed the important role for KLF4 inMET
during reprogramming (Li et al., 2010). Furthermore,
PluriNetWork genes, which are associated with pluripo-
tency, are enriched in groups A and B (Figure 5C), and heat-
maps show that all the PluriNetWork genes in groups A and
B increase their expression in a Shield1-dependent manner
(Figure 5D), as if increasing the amount of KLF4 recapitu-
lates the chronological progression of reprogramming.
Independent quantitative RT-PCR analysis of selected plu-
ripotency-related genes (Kim et al., 2008; O’Malley et al.,
2013; Xu et al., 2010) identified two categories of genes
that show distinct expression profiles in response to the(G) Clone Sh0-5 was cultured in the absence of Shield1 until day 50, wh
determined at day 31, 45, 64, 73, and 100. Data represent means ± SEM
Shield1.
(H) SSEA-1 expression was analyzed in paused iPSCs (Sh0-5) 29 days
vector expressing KLF4, OCT4, SOX2, or c-MYC. Scale bars, 100 mm.
See also Figure S4 and Table S2.
Stem Cell RShield1 amount; genes that increase expression gradually
as the amount of Shield1 is increased (upper panel, Figures
5E and S5F–S5M) and genes that increase expression mark-
edly at 30 nM or higher concentrations of Shield1 (lower
panel, Figures 5E and S5N–S5U). The former and the latter
categories of genes correspond more or less to the genes
in group A and group B, respectively (Figures 5D and 5E),
demonstrating that pluripotency-related genes respond
to the KLF4 level by at least two distinguishable modes.
Together, the global gene expression analyses indicate
that the iPSCs generated by the 3S reprogramming system
are paused at critical stages of reprogramming and suggest
that the KLF4-dependent transitions from one stage to the
next is accompanied by changes in the expression of genes
that are crucial for reprogramming.
Generation of Partially Reprogrammed Human iPSCs
Althoughmolecularmechanismsofmouse iPSCgeneration
have been investigated substantially, there have been rela-
tively few mechanistic analyses of human iPSCs. Because
our SeVdp vectors have been used successfully to generate
human iPSCs from various somatic cells (Nishimura et al.,
2013; Takayama et al., 2010; Tateno et al., 2013; Wakao
et al., 2013), we tested if the 3S reprogramming system
generates human iPSCs that have paused during reprog-
ramming. When SeVdp(KOSM) and SeVdp(GKOSM) were
infected to human fibroblasts, both vectors produced
ALP+ colonies of small, rapidly growing cells in a similar
manner to MEFs, although SeVdp(GKOSM) induced
slightly more colonies than SeVdp(KOSM) (Figure 6A;
Table S1). SeVdp(GKOSM)-induced human cells are similar
to theirmouse counterparts (Figure 1B) in that they are pos-
itive forALPbutnegative for ESCmarkers,CDH1, FGF4, and
REX1 (Figure 6B).
When human fibroblasts were infected with SeVdp(fK-
OSM) in the presence or absence of 100 nM Shield1, similar
numbers of ALP+ colonies were obtained regardless of the
presence of Shield1 (Figure 6A; Table S1). However, induc-
tion in the absence of Shield1 generated cells that were
negative for CDH1, FGF4, and REX1, whereas induction
in the presence of 100 nM Shield1 generated cells that
expressed these ESC marker genes (Figure 6B). Moreover,
as in the case of mouse iPSCs (Figure 3C), hiPSCs generated
by SeVdp(fK-OSM) in the presence of 100 nM Shield1 were
cleared of the vector by the siRNA against the L gene to
establish vector-free hiPSCs (Figure S6). These resultsen Shield1 was added. The mRNA levels of Cdh1, Fgf4, and Rex1 were
of three independent experiments. *p < 0.05 versus no addition of
after the addition of 100 nM Shield1 or infection with a retroviral
eports j Vol. 3 j 915–929 j November 11, 2014 j ª2014 The Authors 923
(legend on next page)
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rammed human iPSCs that are similar to the pausedmouse
iPSCs as well as fully reprogrammed iPSCs that have
acquired a self-sustaining pluripotency state. Thus, the 3S
reprogramming system can be utilized to generate partially
reprogrammed human iPSCs, and these cells will be useful
for analyzing the mechanism of human iPSC generation.DISCUSSION
Understanding the mechanisms of iPSC generation is
important for application for cell therapy and also provides
insights into the molecular mechanisms of normal devel-
opmental processes. The analysis, however, suffers from
technical limits because the intermediate cells in the pro-
cess of reprogramming are transient, asynchronous and
heterogeneous. Cell sorting enriches intermediate cells,
but they are transient and limited in amount (Hansson
et al., 2012; O’Malley et al., 2013; Polo et al., 2012). For
example, SSEA-1+ Oct4 reprogramming intermediates,
initially isolated by fractionation using SSEA-1 antigen,
diversify into a heterogeneous population of cells upon
continued cell culture; some of them revert to lose SSEA-1
expression, whereas others advance to initiate Oct4 expres-
sion (Polo et al., 2012). Partially reprogrammed cell popula-
tions obtained during iPSC generation are relatively stable
and expandable, but they are usually sporadic and unpre-
dictable byproducts of reprogramming (Mikkelsen et al.,
2008; Sridharan et al., 2009), sometimes generating aber-
rantly reprogrammed cells that do not transit into the
pluripotent state (Mikkelsen et al., 2008).
Unlike these previous methods, the 3S reprogramming
system generates partially reprogrammed iPSCs in a repro-
ducible and predictable manner by regulating the amount
of KLF4. These cells resume reprogramming upon increased
KLF4 expression and therefore are not aberrantly reprog-
rammed but have paused during iPSC generation. Different
KLF4 levels yield paused iPSCs at a series of stages duringFigure 5. Global Gene Expression Profiles of Paused iPSCs
(A) Hierarchical clustering of paused iPSCs based on gene expression
and miPSCs (p < 0.05). Analyzed samples include cells induced by SeVd
Shield1 for 22 or 79 days. Cells that resumed reprogramming (Sh0/
Shield1 for 25 days and then cultured in the presence of 100 nM Shie
(B) Hierarchical clustering of DEGs. DEGs between MEFs and miPSCs
indicated cells and classified into five groups (group A–E).
(C) Enriched pathways in the genes of groups A, B, or D.
(D) Heatmap of the expression profiles of PluriNetWork genes cluster
(E) Two distinct expression profiles of pluripotency-related genes
cells were cultured in the presence of indicated concentrations of Sh
pluripotency-related genes were determined by quantitative RT-PCR.
See also Figure S5 and Table S2.
Stem Cell RiPSC generation, enabling themolecular analysis of orderly
events that proceed during reprogramming. Moreover,
the paused iPSCs are relatively homogeneous and pheno-
typically stable, allowing expansion of cells for further
analyses. Last, this system is based upon a defective Sendai
virus, which replicates exclusively in the cytoplasm (Nish-
imura et al., 2011), and thus is free fromboth the positional
effects and the silencing of transgenes that may arise in the
systems based upon the retrovirus or lentivirus (Jaenisch
et al., 1981). Therefore, our system to generate paused
iPSCs is a significant advance over the sorted cells and
partially reprogrammed cell populations previously used
for mechanistic analyses of iPSC generation.
It remains to be determined how the low expression of
KLF4, but not the other three factors, generates paused
iPSCs. It is known that KLF4 represses somatic gene
expression together with c-MYC at an early stage of iPSC
generation and enhances pluripotency gene expression in
cooperation with OCT4 and SOX2 at its late stage (Polo
et al., 2012). Therefore, reduced levels of KLF4 may be suf-
ficient for repressing somatic cell-specific genes, but not for
activating pluripotency-related genes. A recent study also
showed that KLF4 organizes long-range chromosomal
interactions with the Oct4 locus by recruiting cohesion
(Wei et al., 2013). These chromosomal interactions are
observed not in SSEA-1 cells but only in SSEA-1+ cells
during reprogramming, suggesting that KLF4 may mediate
the chromosomal reorganization during the transition
from the SSEA-1 to SSEA-1+ cells. Interestingly, this corre-
sponds to a stage where SeVdp(fK-OSM) generates paused
iPSCs in the absence of Shield1. It is thus possible that
such dynamic chromosomal reorganization requires a
high level of KLF4 and presents a roadblock for reprogram-
ming with a low expression level of KLF4.
Recently, Sui et al. reported production of partially reprog-
rammed iPSCsusing trimethoprim (TMP)-regulateddestabi-
lizing domain to control the expression of reprogramming
factors from a piggyBac transposon vector (Sui et al., 2014).
In contrast to our 3S reprogramming system, SOX2 ratherprofiles of the differentially expressed genes (DEGs) between MEFs
p(fK-OSM) at the indicated concentrations (0, 10, 30, or 100 nM) of
100 79d) were first induced by SeVdp(fK-OSM) in the absence of
ld1 before collection at day 79.
(p < 0.05) were clustered based on gene expression profiles of the
ed in group A or B.
at increasing concentrations of Shield1. SeVdp(fK-OSM)-infected
ield1, and the cells were collected at day 27. The mRNA levels of
Data represent mean ± SEM of three independent experiments.
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Figure 6. Generation of Partially Reprogrammed iPSCs from
Human Somatic Cells
(A) Generation of ALP+ human iPSCs by SeVdp(fK-OSM). The indi-
cated SeVdp vectors were used to generate human iPSCs, and the
cells were stained for ALP at day 16. Scale bars, 100 mm.
(B) Expression of ESC markers in partially reprogrammed human
iPSCs. The mRNA levels of CDH1, FGF4, and REX1 in the cells infected
by the indicated vector in the presence or absence of 100 nM
Shield1 were determined by quantitative RT-PCR at day 18.
Data represent means ± SEM of three independent experiments.
*p < 0.05, **p < 0.01 versus SeVdp(KOSM)-infected cells.
See also Figure S6 and Tables S1 and S2.
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gression of reprogramming. Several reasons may account
for this apparent discrepancy. First, each system employed
a different combination of the vector and reprogramming
factors for iPSC generation. Sui et al. used only OCT4,
SOX2, and KLF4 in piggyBac transposon vectors whereas
our system used OCT4, SOX2, KLF4, and c-MYC in SeVdp
vectors. Second, unlike the FKBP-based domain used in
our system, thedestabilizing domainused by Sui et al. seems
to promote more complete protein degradation. Third,
reprogramming may proceed via distinct pathways in each
systemand therefore the role for each reprogramming factor
may not be identical between different systems. In fact,926 Stem Cell Reports j Vol. 3 j 915–929 j November 11, 2014 j ª2014 Therecent studies indicate the presence of multiple pathways
by which reprogramming proceeds toward pluripotency
(O’Malley et al., 2013; Parchem et al., 2014; Rais et al.,
2013).Given this possibility, the availability of different sys-
tems that may generate iPSCs stalled at alternative interme-
diate states should be invaluable for more comprehensive
understanding of the reprogramming process.
Regardless of the effect of the KLF4 expression level
on the progression of reprogramming, the 3S reprogram-
ming system described here provides a powerful tool for
analyzing the mechanism of iPSC generation, particularly
with respect to its ill-defined intermediate stages. One
such example is MET, a reverse process of EMT that occurs
during normal development. Consistent with the role for
KLF4 in MET (Li et al., 2010), the paused iPSCs generated
in the absence of Shield1 have stalled around MET and
show gene expression profiles reminiscent of the ongoing
MET. Another is the primitive streak-like mesendodermal
(PSMN) state, where cells transiently display gene expres-
sion profiles resembling mesendoderm (Takahashi et al.,
2014), which forms part of the primitive streak during early
embryonic development. Paused iPSCs generated in the
presence of 10–30 nM Shield1 express mesendoderm-
related genes but have not reached the fully reprogrammed
state. Because the addition of Shield1 permits the paused
iPSCs to advance toward the fully reprogrammed state in
a controlled manner, the 3S reprogramming system may
be especially suitable for analyzing the MET stage, the mes-
endodermal stage as well as the late stage toward pluripo-
tency. Finally, in addition to MEF-based iPSC generation,
the current system also works for human somatic cells.
Thus, the 3S reprogramming system will offer a unique
opportunity to analyze transient and unstable stages of
iPSC generation from mouse and human somatic cells.EXPERIMENTAL PROCEDURES
Cell Culture and Generation of iPSCs
Mouse iPSCs were generated from mouse embryonic fibroblasts
(MEFs) isolated from a transgenic mouse carrying the Nanog-GFP-
IRES-Puror reporter construct (Okita et al., 2007) (provided by the
RIKEN BioResource Center) (Nanog-GFP MEFs). After Nanog-GFP
MEFs were infected with each SeVdp vector at 32C for 14 hr at
an MOI of about 5, 2.0 3 104 of infected cells were seeded onto
mitomycinC-treatedMEFs in 6-well plates and cultured inKSRme-
dium (Knockout-DMEM (Life Technologies) supplemented with
15% Knockout Serum Replacement (Life Technologies), 2 mM
GlutaMAX (Life Technologies), 0.1 mM nonessential amino acids
(Life Technologies), 55 mM2-mercaptoethanol (Life Technologies),
100 U/ml penicillin-streptomycin (Wako), and 1,000 U/ml LIF
[Wako]) for 7 days, and then in mES medium (DMEM; nacalai
tesque) supplemented with 15% fetal bovine serum (Hyclone),
0.1 mM nonessential amino acids, 55 mM 2-mercaptoethanol,
100 U/ml penicillin-streptomycin and 1,000 U/ml LIF), in theAuthors
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Low KLF4 Expression Generates Paused iPSCspresence or absence of Shield1 (Takara Bio). The presence of the
vector in MEFs was confirmed 1 day after infection by immuno-
staining using an anti-SeV NP monoclonal antibody (Nishimura
et al., 2011) as described in Supplemental Experimental Proce-
dures. Reprogrammed cells were maintained on mitomycin
C-treated SNL76/7 feeder cells (DS Pharma Biomedical) in the
same mES medium, which was changed every 2 days. To remove
SeVdp vectors from the reprogrammed cells, the cells were treated
with 40 nM of L527 siRNA (Nishimura et al., 2011) mixed with
Lipofectamine RNAi MAX Transfection Reagent (Life Technolo-
gies) in every passage after about day 20.
Human iPSCs were generated from human skin fibroblast
NB1RGB cells (RIKEN BioResource Center). The cells were infected
with SeVdp vectors at room temperature for 2 hr followed by 37C
for 14 hr at an MOI of about 5, and 2.0 3 104 of infected cells
were seeded onto mitomycin C-treated MEFs in 6-well plates
and cultured in Primate ESC culture medium (ReproCell) with
5 ng/ml basic FGF (Wako).
Retroviral vectors were infected to partially reprogrammed Sh0-5
cells cultured under a feeder-free condition at an MOI of about 10
for 2 days with 8 mg/ml of Hexadimethrine bromide (polybrene;
Sigma). The cells were then passaged onto feeder cells and cultured
in mES medium.
Determination of Protein Expression by Western
Blotting
After SeVdp vectors were infected to MEFs, the cells were collected
one day after infection and lysed on ice in SDS-PAGE gel
loading buffer (50 mM Tris-HCl [pH 6.8], 2% SDS, 10% glycerol,
0.1 mg/ml Bromophenol blue, 5% 2-mercaptoethanol), followed
by boiling for 5 min, and the whole-cell extracts were subjected
to western blot analysis. Antibodies against SOX2, KLF4 or
c-MYC were prepared by immunizing rabbits with each purified
recombinant protein, as described previously (Fukuda et al.,
2013). Each full-length recombinant protein was expressed in
BL21(DE3)pLysS, separated by SDS-PAGE, and electroeluted. The
purified recombinant proteins were used to immunize rabbits
by Japan Bio Serum, and the obtained sera were affinity-purified
by a corresponding antigen column, in which glutathione
S-transferase (GST)-tagged proteins was crosslinked to glutathione
Sepharose 4B (GE Healthcare). Anti-OCT4 (1:5,000, ab19857,
Abcam) and anti-a-TUBULIN (1:10,000, ab7291, Abcam) were
purchased commercially. Blots were probed with anti-rabbit or
anti-mouse IgG-HRP secondary antibody (1:5,000, GE Healthcare)
and visualized using Luminol, p-Coumaric acids, and H2O2 (Mruk
and Cheng, 2011). Intensity of the chemiluminescence was quan-
tified by LAS4000 (GE Healthcare) using ImageQuant TL software
(GE Healthcare). We calculated the relative protein expression
level of each reprogramming factor by normalizing on the basis
of a-TUBULINprotein expression as described in Figure S1C.Deter-
mination of protein expression was carried out from biologically
triplicate experiments.
Characterization of Mouse and Human iPSCs
Detailed methods for immunofluorescence, ALP staining, quanti-
tative RT-PCR, microarray analysis, and generation of chimeric
mice are described in Supplemental Experimental Procedures.Stem Cell RAll animal experiments were performed according to the Guide
for the Care and Use of Laboratory Animals at the University of
Tsukuba.
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